Vaccine · 2026
2023-2024 COVID-19 vaccination coverage in pregnancy in ten healthcare delivery organizations in the United States.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Irving Stephanie A, Crane Bradley, Daley Matthew F, Dixon Brian E, Donahue James G, Fuller Candace C, Jackson Lisa A, Getahun Darios, Glenn Sungching C, Hambidge Simon J, Jacobson Karen B, Kharbanda Elyse O, O'Leary Sean T, Schmidt Teresa, Raisler Katharine, Weinfield Nancy S, Williams Joshua T B, Zerbo Ousseny, Naleway Allison L
Аннотация
Data on COVID-19 vaccination coverage in pregnancy are sparse, with most literature focused on original monovalent and bivalent vaccines. We assessed coverage of 2023-2024 COVID-19 vaccines among pregnant women across ten health care organizations in the United States participating in the Vaccine Safety Datalink (VSD). Among 167,478 women aged 18-49 years with a pregnancy during September 2023-August 2024, 23,941 (14.3%) received a 2023-2024 COVID-19 vaccine dose prior to or during their pregnancy. We identified higher coverage with increasing age groups (range 4.8% to 21.2% vaccinated) and increasing healthcare utilization during pregnancy (range 9.8% to 17.6% vaccinated). We found differences in coverage by maternal race and ethnicity (range 7.2% to 23.2% vaccinated), and by calendar month of pregnancy start (range 1.3% to 17.6% vaccinated). Uptake of 2023-2024 COVID-19 vaccines was low in this population. The VSD will continue monitoring COVID-19 vaccination coverage in pregnancy in the 2024-2025 season, including coverage by maternal race and ethnicity.